Fekety R, Shah A B
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor.
JAMA. 1993 Jan 6;269(1):71-5.
Pseudomembranous colitis associated with antibiotic therapy is almost always due to an overgrowth of Clostridium difficile. If untreated, pseudomembranous colitis can lead to severe diarrhea, hypovolemic shock, toxic dilatation of the colon, cecal perforation, hemorrhage, and death. However, C difficile-associated colitis can mimic the more common "benign" antibiotic-associated diarrhea that is not caused by C difficile. An algorithm for diagnosis management of hospitalized patients with antibiotic diarrhea and C difficile colitis is presented in this review. Diagnosis depends on sigmoidoscopy and/or stool tests for C difficile toxins in all patients with antibiotic-associated diarrhea. If the results of these tests are positive, either metronidazole or vancomycin is recommended for treatment of mild illness, and vancomycin is recommended for treatment of severe illness. Oral therapy is always preferred because it is more reliable. In patients with recurrent or relapsing colitis, treatment with either metronidazole or vancomycin is effective for that episode, but novel approaches, such as the oral or rectal introduction of competing nonpathogenic organisms, may prove to be more successful in prevention of relapses.
与抗生素治疗相关的伪膜性结肠炎几乎总是由艰难梭菌过度生长引起的。如果不进行治疗,伪膜性结肠炎可导致严重腹泻、低血容量性休克、结肠中毒性扩张、盲肠穿孔、出血和死亡。然而,艰难梭菌相关性结肠炎可能会模仿更常见的并非由艰难梭菌引起的“良性”抗生素相关性腹泻。本文综述了针对住院的抗生素相关性腹泻和艰难梭菌结肠炎患者的诊断管理算法。对于所有抗生素相关性腹泻患者,诊断依赖于乙状结肠镜检查和/或检测粪便中的艰难梭菌毒素。如果这些检测结果呈阳性,对于轻症患者,推荐使用甲硝唑或万古霉素进行治疗,对于重症患者,推荐使用万古霉素进行治疗。口服治疗始终是首选,因为它更可靠。对于复发性或复发性结肠炎患者,使用甲硝唑或万古霉素治疗该发作有效,但新的方法,如口服或直肠引入竞争性非致病微生物,可能在预防复发方面更成功。